Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company National OncoVenture
DescriptionHumanized IgG4 antibody targeting hepatocyte growth factor (HGF)
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationLeiomyosarcoma
Indication DetailsTreat leiomyosarcoma (LMS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today